| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8508266 | Actualités Pharmaceutiques | 2018 | 5 Pages |
Abstract
The prescribing of a pharmaceutical speciality for an unapproved use, in terms of an indication, a posology or a particular population can lead to the non-respect of the initial marketing authorisation (MA), or being off-label. The respect of the MA imposes specific precautions and responsibilities not only for the prescribing physician but also for the pharmacist dispensing the medication.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Aurore (Docteur en pharmacie), Marie-Laure (Docteur en médecine, Professeur des Universités-praticien hospitalier), Anne (Docteur en pharmacie, praticien attaché),